The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
Главные авторы: | Fokas, E, Prevo, R, Reaper, P, Charlton, P, Pollard, J, Mckenna, W, Muschel, R, Brunner, T |
---|---|
Формат: | Conference item |
Опубликовано: |
2012
|
Схожие документы
-
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
по: Prevo, R, и др.
Опубликовано: (2012) -
ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
по: Fokas, E, и др.
Опубликовано: (2013) -
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
по: Fokas, E, и др.
Опубликовано: (2012) -
Targeting ATR in DNA damage response and cancer therapeutics.
по: Fokas, E, и др.
Опубликовано: (2014) -
Targeting ATR in DNA damage response and cancer therapeutics
по: Fokas, E, и др.
Опубликовано: (2014)